Purdue Pharma to pay more than $8bn to end US opioid case

purdue pharma agreed to pay more than $8bn to resolve its role in the us opioid epidemic. the deal clears the way for billions to reach cities and states that have been devastated by addiction and overdose deaths. the settlement ends a long-running legal fight over the company's marketing of oxycontin. purdue had previously filed for bankruptcy as part of earlier settlement attempts. the new payout is structured to distribute funds directly to local governments and health programs across the country.